Close this search box.

We are creating some awesome events for you. Kindly bear with us.

RMIT University collaborates for new technology in early detection of Type 1 diabetes

RMIT University collaborates for new technology in early detection of Type 1 diabetes

New technology for early detection of Type
1 diabetes is being developed by researchers. This technology will be able to
accurately predict if a child is at risk of the chronic disease.

Around 542,000 children all over the world
are affected with the Type 1 diabetes. An increasing number of adults are also
being diagnosed with this lifelong autoimmune disorder. No early tests are
available for this type of diabetes so by the time a diagnosis is made; about
70% of the critical insulin-producing cells have been destroyed.

According to the report
released by the RMIT University, the technology being developed by RMIT
scientists and engineers uses a microchip and sensor to detect markers in the
blood that can identify the early loss of beta cells.

Researchers from the RMIT University
and the University of
are collaborating on the detection kit that can one day be
used as a standard test for newborns. Early detection allows for treatments to
be developed, thereby delaying or preventing its onset.

Director of the Ian
Potter NanoBioSensing Facility
at RMIT, Professor Vipul Bansal said,
“Being able to detect this disease well before it has a chance to progress
would be life-changing for the 2400 Australians diagnosed with Type 1 diabetes
each year.”

He added, “The detection kit we’re
developing is cost-effective and simple to use, requiring no specialist
technical knowledge or expensive analysis.”

There are about 20 biomarkers in the blood
that can accurately predict the health of beta cells. This was previously
discovered by a team of researchers at the University of Sydney, which was led
by Associate Professor Anand Hardikar.

Found in the pancreas, beta cells are the
body’s only way of making insulin. Unfortunately, people suffering from Type 1
diabetes cannot produce this sugar-regulating hormone.

Building on that breakthrough, the aim of this
collaboration is to develop a point-of-care device that would test for these
biomarkers and produce results within minutes.

Scientists at RMIT’s Ian Potter
NanoBiosensing Facility have already developed a proof-of-concept sensor coated
with special nanoparticles, which can reliably detect the presence of select
biomarkers. If a particular molecule is present in the blood, a change in
colour would occur.

Nano Research Facility
(MNRF) engineers will
help with expanding the sensor’s capabilities and miniaturise it onto a
microfluidic chip about the size of a postage stamp.

MNRF Director Professor Arnan Mitchell said
that the final result would be a simple and reliable tool for health

He shared, “The prototype we’re building
will be able to analyse just a pin-prick of blood from a patient and provide a
score that indicates the risk of Type 1 diabetes.”

He explained, “The ultimate aim is to be
able to slow or prevent the onset of Type 1 Diabetes. The test could also significantly
boost the development of therapies to prevent or delay the disease.”

He added, “We know the separate components
of the device work, so now the challenge is to bring the sensor and the chip
together into one easy-to-use device.”

Over A$ 1.2 million in funding grant from
The Leona M and Harry B Helmsley Charitable Trust is supporting the research. The
funding grant is administered by JDRF Australia, the nation’s peak body
supporting research into Type 1 Diabetes.


Qlik’s vision is a data-literate world, where everyone can use data and analytics to improve decision-making and solve their most challenging problems. A private company, Qlik offers real-time data integration and analytics solutions, powered by Qlik Cloud, to close the gaps between data, insights and action. By transforming data into Active Intelligence, businesses can drive better decisions, improve revenue and profitability, and optimize customer relationships. Qlik serves more than 38,000 active customers in over 100 countries.


As a Titanium Black Partner of Dell Technologies, CTC Global Singapore boasts unparalleled access to resources.

Established in 1972, we bring 52 years of experience to the table, solidifying our position as a leading IT solutions provider in Singapore. With over 300 qualified IT professionals, we are dedicated to delivering integrated solutions that empower your organization in key areas such as Automation & AI, Cyber Security, App Modernization & Data Analytics, Enterprise Cloud Infrastructure, Workplace Modernization and Professional Services.

Renowned for our consulting expertise and delivering expert IT solutions, CTC Global Singapore has become the preferred IT outsourcing partner for businesses across Singapore.


Planview has one mission: to build the future of connected work. Our solutions enable organizations to connect the business from ideas to impact, empowering companies to accelerate the achievement of what matters most. Planview’s full spectrum of Portfolio Management and Work Management solutions creates an organizational focus on the strategic outcomes that matter and empowers teams to deliver their best work, no matter how they work. The comprehensive Planview platform and enterprise success model enables customers to deliver innovative, competitive products, services, and customer experiences. Headquartered in Austin, Texas, with locations around the world, Planview has more than 1,300 employees supporting 4,500 customers and 2.6 million users worldwide. For more information, visit


SIRIM is a premier industrial research and technology organisation in Malaysia, wholly-owned by the Minister​ of Finance Incorporated. With over forty years of experience and expertise, SIRIM is mandated as the machinery for research and technology development, and the national champion of quality. SIRIM has always played a major role in the development of the country’s private sector. By tapping into our expertise and knowledge base, we focus on developing new technologies and improvements in the manufacturing, technology and services sectors. We nurture Small Medium Enterprises (SME) growth with solutions for technology penetration and upgrading, making it an ideal technology partner for SMEs.


HashiCorp provides infrastructure automation software for multi-cloud environments, enabling enterprises to unlock a common cloud operating model to provision, secure, connect, and run any application on any infrastructure. HashiCorp tools allow organizations to deliver applications faster by helping enterprises transition from manual processes and ITIL practices to self-service automation and DevOps practices. 


IBM is a leading global hybrid cloud and AI, and business services provider. We help clients in more than 175 countries capitalize on insights from their data, streamline business processes, reduce costs and gain the competitive edge in their industries. Nearly 3,000 government and corporate entities in critical infrastructure areas such as financial services, telecommunications and healthcare rely on IBM’s hybrid cloud platform and Red Hat OpenShift to affect their digital transformations quickly, efficiently and securely. IBM’s breakthrough innovations in AI, quantum computing, industry-specific cloud solutions and business services deliver open and flexible options to our clients. All of this is backed by IBM’s legendary commitment to trust, transparency, responsibility, inclusivity and service.